Interictal serum L-kynurenine and PACAP-38 levels in relation to allodynia and migraine subtypes

What Was Tested

The paper reports a study of PACAP in the context of migraine, published as an observational study.

This study aimed to evaluate the relationship between serum levels of L-kynurenine (L-KYN) and pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38), two molecules implicated in migraine pathophysiology and migraine subtypes (episodic and chronic), as well as the presence of allodynia.

The researchers hypothesized that dysregulation of the kynurenine pathway and prepro-pituitary adenylate cyclase-activating polypeptide (PACAP) signaling would be reflected in altered serum L-KYN and PACAP-38 levels across migraine subtypes and in relation to allodynia.

Why It Was Studied

Migraine is a complex neurological disorder characterized by central sensitization and trigeminovascular activation.

Although the kynurenine pathway and PACAP-38 have been implicated in migraine pathophysiology, their associations with migraine subtypes and allodynia remain insufficiently understood.

Who Took Part

According to the abstract, 137 patients were involved.

By PubMed's age tags, the people studied were adults and middle-aged adults, both men and women.

In this observational cross-sectional study, a total of 137 patients diagnosed with migraine who presented to the neurology outpatient clinic of a tertiary university hospital, and 40 age- and sex-matched healthy volunteers as a control group, were included.

Interictal serum L-KYN and PACAP-38 levels were measured in all participants using the enzyme-linked immunosorbent assay.

How the Study Was Run

Clinical assessments comprised the Beck Depression Inventory, Beck Anxiety Inventory, MIDAS, Allodynia Symptom Checklist, and a visual analogue scale.

Data analyses included nonparametric tests, correlation analyses, and multivariable logistic and robust regression models.

What Was Measured

PubMed files the paper under topics including Pituitary Adenylate Cyclase-Activating Polypeptide, Hyperalgesia, Kynurenine, Cross-Sectional Studies, Migraine Disorders and Biomarkers.

Author keywords: L‐kynurenine, PACAP‐38, allodynia, central sensitization, chronic migraine and episodic migraine.

What This Means in Plain Language

This is an observational study of PACAP in 137 patients in people with migraine.

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2026 (Headache), a journal based in United States.

More context: the PACAP compound page, Migraine research.